Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
P2.01-46 The Efficacy and Safety of 2nd-Line Nivolumab for Non-Small Cell Lung Cancer in Real-World Practice with Emphasis on Hyperprogession
PaperCitations, authors & open-access status
P2.01-46 The Efficacy and Safety of 2nd-Line Nivolumab for Non-Small Cell Lung Cancer in Real-World Practice with Emphasis on Hyperprogession is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2 citations, 2019 year and bronze oa status.
2
Citations
2019
Year
bronze
OA Status